Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study

Stéphane Leprêtre; Aurore Touzart; Thomas Vermeulin; Jean‐Michel Picquenot; Aline Schmidt; Gilles Salles; Thierry Lamy; Marie C. Béné; Emmanuel Raffoux; Françoise Huguet; Patrice Chevallier; Serge Bologna; Réda Bouabdallah; Jacques Bénichou; Josette Brière; Philippe Moreau; Valérie Tallon-Simon; Stéphanie Seris; Carlos Graux; Vahid Asnafi; Norbert Ifrah; Elizabeth Macintyre; Hervé Dombret

doi:10.1200/jco.2015.61.5385

Abstract

This is the authors' abstract. We don't add key points for this paper.

In adults with LL, an intensive pediatric-like ALL treatment protocol was associated with a good response rate and outcome. In patients with T-LL, the four-gene oncogenetic classifier and lactate dehydrogenase level were independent prognostic indicators.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Leprêtre et al. (2015) studied this question.

synapsesocial.com/papers/69dd608b0a7b4bc8c4101d4c https://doi.org/10.1200/jco.2015.61.5385

View Full Paper

Ask AI

Bookmark

Share

Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study

Abstract

Ask about this paper

Discussion

Cite This Study

Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading